Search by Drug Name or NDC

    NDC 31722-0019-12 Diatrizoate Meglumine and Diatrizoate Sodium 660; 100 mg/mL; mg/mL Details

    Diatrizoate Meglumine and Diatrizoate Sodium 660; 100 mg/mL; mg/mL

    Diatrizoate Meglumine and Diatrizoate Sodium is a ORAL; RECTAL SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Camber Pharmaceuticals, Inc.. The primary component is DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM.

    Product Information

    NDC 31722-0019
    Product ID 31722-019_0cd6854c-dae9-9cd7-e063-6394a90a8dfe
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name Diatrizoate Meglumine and Diatrizoate Sodium
    Proprietary Name Suffix n/a
    Non-Proprietary Name Diatrizoate Meglumine and Diatrizoate Sodium
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form SOLUTION
    Route ORAL; RECTAL
    Active Ingredient Strength 660; 100
    Active Ingredient Units mg/mL; mg/mL
    Substance Name DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM
    Labeler Name Camber Pharmaceuticals, Inc.
    Pharmaceutical Class Radiographic Contrast Agent [EPC], Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA], X-Ray Contrast Activity [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA215049
    Listing Certified Through 2024-12-31

    Package

    NDC 31722-0019-12 (31722001912)

    NDC Package Code 31722-019-12
    Billing NDC 31722001912
    Package 12 BOTTLE in 1 BOX (31722-019-12) / 120 mL in 1 BOTTLE
    Marketing Start Date 2023-11-17
    NDC Exclude Flag N
    Pricing Information N/A
    << 31722-0018-10 31722-0019-30 >>

    Contents